Nearly Half of Cancer Patients Taking Ivermectin & Mebendazole Reported Tumor Disappearance or Reduction After 6 Months
A groundbreaking 2026 real-world study has found that 84.4% of cancer patients taking a combination of ivermectin and mebendazole reported measurable clinical benefit after just six months — including nearly half who reported tumor disappearance or significant reduction. The Study Researchers led by epidemiologist Nicolas Hulscher (MPH), alongside Dr. Peter McCullough, Dr. Harvey Risch (Chairman […]
